Exosome Research Products Market Size to Surpass USD 2.26 Billion with a Growing CAGR of 19.3% by 2030, Size, Share, Trends, Competitive Landscape and Regional Overview
MONTREAL, Feb. 7, 2023 /PRNewswire/ -- Data Bridge Market Research has recently published the comprehensive business research on "Exosome Research Products Market " includes historic data, present market trends, future product environment, marketing strategies, technological innovation, upcoming technologies, emerging trends or opportunities, and the technical progress in the related industry. Exosome Research Products Market research report gives critical information about the market and business landscape. It suggests how the company is perceived by the target customers and clients that are desired to reach. The report helps understand how to connect with customers, how to stack up against the competition, and how to plan next steps. It plays an important role in the process of developing products and services, bringing them to the marketplace, and marketing them to consumers. For many businesses, Exosome Research Products Market report acts as a key component in developing marketing strategy by providing a fact-based foundation for estimating sales and profitability.
Data Bridge Market Research analyses that the exosome research products market which was USD 0.55 billion in 2022, would rocket up to USD 2.26 billion by 2030, and is expected to undergo a CAGR of 19.3% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Get a Sample PDF of Exosome Research Products Market @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-exosome-research-products-market
According to WHO, cancer is a top cause of death globally, accounting for approximately 10 million deaths in 2020. Governments of several developing countries are making major investments to update health care infrastructure in their respective countries that is predicted to increase access to health care. The increasing number of articles pertaining to exosomal research is encouraging R&D activities in the field.
Exosomes are secreted by diverse cells and exist in the body fluids such as blood, saliva, urine and serum. They have a diameter of 30nm to 120 nm and contain RNA and protein cargos. They perform physiological and pathological functions. Exosomes are very beneficial in cancer or neurodegenerative diseases and also infections. They have a major role in the communication and rejuvenation of all cells in the body. The communication between cells is important to keep a good health or a healthy cellular terrain.
Top Leading Key Players of Exosome Research Products Market:
- Hologic, Inc. (U.S.)
- Luminex (U.S.)
- BD (U.S.)
- Abbott (U.S.)
- Thermo Fisher Scientific Inc. (U.S.)
- QIAGEN (Germany)
- Agilent Technologies Inc. (U.S.)
- Bio-Techne (U.S.)
- System Biosciences, LLC. (U.S.)
- Miltenyi Biotec (U.S.)
- NanoSomiX (U.S.)
- Norgen Biotek Corp (Canada)
- Lonza (Switzerland)
- Novus Biologicals (U.S.)
- NX PharmaGen (U.S.)
- Danaher. (U.S.)
- Hitachi, Ltd (Japan)
- Beckman Coulter, Inc (India)
- Aethlon Medical, Inc. (U.S.)
- ExoDx (U.S.)
- Jazz Pharmaceuticals, Inc (U.K.)
- Boehringer Ingelheim International Gmbh (Germany)
- ReNeuron Group plc (U.K.)
Recent Developments
- In 2022, Bio-Techne made an agreement with Thermo Fisher Scientific for the development of ExoTRU kidney transplant rejection test. This test will be helpful in giving allograft health information that is suitable for clinical applications
- In 2020, Lonza acquired exosome facility of Codiak Biosciences. The latter kept its pipeline of therapeutic candidates and exosome drug-loading technologies
Get Full PDF Research Report @ https://www.databridgemarketresearch.com/checkout/buy/enterprise/global-exosome-research-products-market
A comprehensive analysis will be provided covering the following points in the report:
- Executive Market Summary
- Scope of the Exosome Research Products Report
- Key Finding and Recommendations
- Growth and Investment Opportunities
- Exosome Research Products Market Value Chain/Supply Chain Analysis
- Exosome Research Products Market Attractive Investment Proposition
- Competitive landscape and SWOT Analysis
- Exosome Research Products Market Segmentation Outlook
- Regional Outlook
- Company Profiles of Key Players
Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the Exosome Research Products Industry over the period. Further, Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.
Opportunities
- Increase of Research in Academic And Research Institutes
Academic and research institutes, pharmaceutical and biotechnology businesses, hospitals and clinical testing laboratories are the major end users of the market. There has been a rise in demand for exosome study in the recent years due to their potential in illness detection and their emerging role as intercellular messengers. This has attracted the interest of several academic researchers, leading to the market's growth. More than 6,000 items are currently being examined in clinical trials worldwide, representing a 68% increase over 2016, per the Pharmaceutical R&D spending trends in 2022.
- Rise in Neurogenerative Disorders
Neurodegenerative diseases are the major cause of disability and mortality, along with extensive financial burden on healthcare systems. As per the United Nations report, the number of dementia cases in highly developed countries is projected to increase from 13.5 million in 2000 to 21.2 million in 2025 to 36.7 million in 2050. This rise is anticipated to contribute to an increase in neurodegenerative diseases, major advancements in exosome separation and analysis techniques, and an upsurge in the number of sophisticated exosome applications.
Industry Drivers:
- Rising Prevalence of Cancer
According to WHO, cancer is the foremost cause of mortality worldwide resulting for about 10 million deaths in 2020. The number of patients suffering from cancer in India among males was around 679,421, and for females was almost 712,758 for the year 2020. The number of new cancer cases and deaths in 2021 was around 1.9 million and 608,570 cancer deaths in the United States. Thus, cancer incidence is encouraging researchers to do more and more research and biomarker is really helpful in identifying cancer. Thus, the market growth is increased.
- · Increased R&D Activities
The increasing number of articles relating to exosomal research is boosting R&D activities in the field. Presently, there are more than 4400 articles that are published about exosomes, with about 25% of these published in 2016 alone. Along with the exponential rise in article publication, the wide range of companies that are engaged in the research is also growing. Moreover, an increase in funding for R&D in this field is set to positively influence the industrial growth. Thus, this boost the market growth.
To Gain More Insights About This Market, Visit Here @ https://www.databridgemarketresearch.com/reports/global-exosome-research-products-market
Exosome Research Products Market Segmentations:
Product and Services
- Kits and Reagents
- Antibodies
- Isolation, Purification, Quantitative Kits
- Instruments and Services
Applications
- Cancer Applications
- Non-Cancer Applications
Indication
- Cancer
- Infectious Diseases
End-user
- Hospitals
- Ambulatory Surgical Centers
Exosome Research Products Market Country Level Analysis
The countries covered in the exosome research products market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the exosome research products market due to the increasing focus and rising interest in exosome research and diagnostics and more funding by the government for R&D activities.
Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2023 to 2030 because of increasing expenditure of healthcare infrastructure, growing investments for R&D activities and increased focus of the government.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Restraints/Challenges
- Lack of Skilled Healthcare Professionals
There is a lack of skilled professionals that pose a huge challenge to the rapid growth of exosome research products market. Not all professionals are into this research and thus the market is hampered in a huge way.
This exosome research products market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the exosome research products market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Table of Content
- Introduction
- Market Segmentation
- Executive Summary
- Premium Insights
- Market Overview
- Global Exosome Research Products Market, By Product and Services
- Global Exosome Research Products Market, By Applications
- Global Exosome Research Products Market, By Indication
- Global Exosome Research Products Market, By End-user
- Global Exosome Research Products Market, By Region
- Global Exosome Research Products Market, Company Landscape
- SWOT Analysis
- Company Profile
- Questionnaire
- Related Reports
Download Full Table of Contents @ https://www.databridgemarketresearch.com/toc/?dbmr=global-exosome-research-products-market
Browse More Reports by DBMR:
Exosome Therapeutics Market, By Type (Natural Exosome, Hybrid Exosome), Source (Mesenchymal Stem Cells, Blood, Body Fluids, Urine, Dendritic Cells, Saliva, Milk, and Others), Therapy (Immunotherapy, Chemotherapy, and Gene Therapy), Transporting Capacity (Bio Macromolecules and Small Molecules), Application (Metabolic Disorders, Oncology, Cardiac Disorders, Neurology, Inflammatory Disorders, Organ Transplantation, Gynecology Disorders, Blood Disorders, and Others), Route of administration (Parenteral and Oral), End User (Research and Academic Institutes, Hospitals and Diagnostic Centers), Country (U.S., Mexico, South Korea, Australia, Hong-Kong, Rest of Asia-Pacific, Brazil, Argentina, Venezuela, Colombia, Ecuador, Peru, Uruguay, Costa Rica, Panama, Dominican Republic, Rest of Latin America and Turkey) Industry Trends and Forecast To 2029 - https://www.databridgemarketresearch.com/reports/global-exosome-therapeutic-market
Asia-Pacific Exosome Therapeutics Market, By Type (Natural Exosome, Hybrid Exosome), Source (Mesenchymal Stem Cells, Blood, Body Fluids, Urine, Dendritic Cells, Saliva, Milk, and Others), Therapy (Immunotherapy, Chemotherapy, and Gene Therapy), Transporting Capacity (Bio Macromolecules and Small Molecules), Application (Metabolic Disorders, Oncology, Cardiac Disorders, Neurology, Inflammatory Disorders, Organ Transplantation, Gynecology Disorders, Blood Disorders, and Others), Route of administration (Parenteral and Oral), End User (Research and Academic Institutes, Hospitals and Diagnostic Centers), Country (South Korea, Australia, Hong-Kong, Rest of Asia-Pacific) Industry Trends and Forecast To 2029 - https://www.databridgemarketresearch.com/reports/asia-pacific-exosome-therapeutic-market
Europe Exosome Therapeutic Market By Type (Natural Exosomes, Hybrid Exosomes), Source (Dendritic Cells, Mesenchymal Stem Cells, Blood, Milk, Body Fluids, Saliva, Urine, Others), Therapy (Immunotherapy, Gene Therapy, Chemotherapy), Transporting Capacity (Bio Macromolecules, Small Molecules), Application (Oncology, Neurology, Metabolic Disorders, Cardiac Disorders, Blood Disorders, Inflammatory Disorders, Gynecology Disorders, Organ Transplantation, Others), Route of Administration (Oral, Parenteral), End User (Hospitals, Diagnostic Centers, Research and Academic Institutes), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), Country (Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland and Rest of Europe) Industry Trends and Forecast https://www.databridgemarketresearch.com/reports/europe-exosome-therapeutic-market
North America Exosome Therapeutics Market, By Type (Natural Exosomes, Hybrid Exosomes), Source (Mesenchymal Stem Cell, Blood, Body Fluids, Urine, Dendritic Cells, Saliva, Milk, and Others), Source (T-Lymphocytes and Others), Therapy (Immunotherapy, Gene Therapy, Chemotherapy), Transporting Capacity (Bio Macromolecules and Small Molecules), Application (Metabolic Disorders, Oncology, Cardiac Disorders, Neurology, Inflammatory Disorders, Organ Transplantation, Gynecology Disorders, Blood Disorders, and Others), Route of Administration (Parenteral, Oral), End User (Research and Academic Institutes, Hospitals and Diagnostic Centers), By Country (U.S. & Mexico), Market Trends and Forecast https://www.databridgemarketresearch.com/reports/north-america-exosome-therapeutic-market
Turkey Exosome Therapeutics Market, By Type (Natural Exosome, Hybrid Exosome), Source (Mesenchymal Stem Cells, Blood, Body Fluids, Urine, Dendritic Cells, Saliva, Milk, and Others), Therapy (Immunotherapy, Chemotherapy, and Gene Therapy), Transporting Capacity (Bio Macromolecules and Small Molecules), Application (Metabolic Disorders, Oncology, Cardiac Disorders, Neurology, Inflammatory Disorders, Organ Transplantation, Gynecology Disorders, Blood Disorders, and Others), Route of administration (Parenteral and Oral), End User (Research and Academic Institutes, Hospitals and Diagnostic Centers), Country (Turkey) Industry Trends and Forecast To 2029 - https://www.databridgemarketresearch.com/reports/turkey-exosome-therapeutics-market
Point-of-Care Testing (POCT) Market, By Product (Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Pregnancy and Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products, Rapid Coagulation Testing and Other POC Products), Application (Blood Transfusion, Cardiac Monitoring, Coagulation, Blood Glucose, Haematology, Non- Invasive SPO2 Monitoring, Non- Invasive PCO2 Monitoring, Whole Blood Analysis, Vital Sign Monitoring and Others), Platform (Lateral Flow Assays/Immunochromatography Tests, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays), Prescription Mode (Prescription-Based Testing and OTC Testing), Testing Type (Immunoassays, Cell-Based Assays, Nucleic Acid Amplification Testing, Clinical Chemistry Assays and Hematology), End-User (Hospitals, Clinics, Laboratories, Home Care, Ambulatory Surgery Centers and Others), Distribution Channel (Direct Tender and Retail Pharmacies) https://www.databridgemarketresearch.com/reports/point-care-testing-poct-market
About Data Bridge Market Research, Private Ltd
Data Bridge Market Research is a multinational management consulting firm with offices in India and Canada. As an innovative and neoteric market analysis and advisory company with unmatched durability level and advanced approaches. We are committed to uncover the best consumer prospects and to foster useful knowledge for your company to succeed in the market.
Data Bridge Market Research is a result of sheer wisdom and practice that was conceived and built-in Pune in the year 2015. The company came into existence from the healthcare department with far fewer employees intending to cover the whole market while providing the best class analysis. Later, the company widened its departments, as well as expands their reach by opening a new office in Gurugram location in the year 2018, where a team of highly qualified personnel joins hands for the growth of the company. "Even in the tough times of COVID-19 where the Virus slowed down everything around the world, the dedicated Team of Data Bridge Market Research worked round the clock to provide quality and support to our client base, which also tells about the excellence in our sleeve."
Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe.
Contact Us
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email – corporatesales@databridgemarketresearch.com
Logo:https://mma.prnewswire.com/media/1011053/Data_Bridge_Market_Research_Logo.jpg
Share this article